Omeros | OMER - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Adma Biologics USD 33.74M 16.65M 2026-03
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Cytokinetics USD 5.59M 5.43M 2026-06
Gilead Sciences USD 1000M 445M 2026-06
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 69.29M 19.79M 2026-06
Knight Therapeutics CAD 82.22M 1.03M 2025-12
MacroGenics USD 9.53M 585K 2026-03
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 58.49M 7.75M 2026-06
Pfizer USD 4.09B 498M 2026-06
Rockwell Medical USD 21.28M 1.67M 2024-06
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
United Therapeutics USD 99.5M 33.9M 2026-06
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06